2023 Q3 Form 10-Q Financial Statement

#000149315223027763 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $642.1K $670.7K $377.5K
YoY Change 88.41% 77.68% 1168.31%
% of Gross Profit
Research & Development $21.02K
YoY Change 1.25%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $663.1K $670.6K $377.4K
YoY Change 83.4% 77.68% 1168.25%
Operating Profit
YoY Change
Interest Expense $8.082K $7.321K $827.00
YoY Change 397.97% 785.25% 354.4%
% of Operating Profit
Other Income/Expense, Net -$12.13K $1.101K -$174.8K
YoY Change -96.94% -100.63%
Pretax Income -$675.2K -$669.6K -$779.3K
YoY Change -15.14% -14.08% 132.72%
Income Tax
% Of Pretax Income
Net Earnings -$675.2K -$669.5K -$779.3K
YoY Change -15.14% -14.08% 132.72%
Net Earnings / Revenue
Basic Earnings Per Share -$0.07 -$0.09 -$0.29
Diluted Earnings Per Share -$0.07 -$0.09 -$290.8K
COMMON SHARES
Basic Shares Outstanding 11.63M shares 11.08M shares 2.680M shares
Diluted Shares Outstanding 9.109M shares 7.074M shares 2.680M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.983M $779.2K $1.424M
YoY Change 669.03% -45.28% 65.04%
Cash & Equivalents $4.681M $779.2K $1.424M
Short-Term Investments
Other Short-Term Assets $5.302M $9.860K $42.99K
YoY Change 5639.72% -77.06% 838.65%
Inventory
Prepaid Expenses $473.4K $9.856K $42.99K
Receivables
Other Receivables
Total Short-Term Assets $10.46M $789.1K $1.467M
YoY Change 651.98% -46.21% 69.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $802.0K $822.2K $779.5K
YoY Change 8.56% 5.48% 25.63%
Other Assets
YoY Change
Total Long-Term Assets $802.0K $822.2K $779.5K
YoY Change 8.56% 5.48% 25.63%
TOTAL ASSETS
Total Short-Term Assets $10.46M $789.1K $1.467M
Total Long-Term Assets $802.0K $822.2K $779.5K
Total Assets $11.26M $1.611M $2.247M
YoY Change 428.74% -28.28% 50.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $812.7K $809.8K $824.2K
YoY Change 0.32% -1.74% 114.63%
Accrued Expenses $21.22K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $690.1K
YoY Change -100.0% -100.0% 4170.61%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.273M $1.310M $1.991M
YoY Change -45.91% -34.22% 36.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.273M $1.310M $1.991M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.273M $1.310M $1.991M
YoY Change -45.91% -34.22% 36.17%
SHAREHOLDERS EQUITY
Retained Earnings -$4.327M -$3.652M -$1.294M
YoY Change 107.05% 182.16%
Common Stock $1.758K $1.107K $868.00
YoY Change 102.53% 27.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.986M $301.5K $255.3K
YoY Change
Total Liabilities & Shareholders Equity $11.26M $1.611M $2.247M
YoY Change 428.74% -28.28% 50.99%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$675.2K -$669.5K -$779.3K
YoY Change -15.14% -14.08% 132.72%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$397.9K -$133.0K -$129.2K
YoY Change 216.05% 2.9% 186.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$40.00K $0.00 $179.8K
YoY Change -100.0% 8261.4%
Cash From Investing Activities -$40.00K $0.00 $179.8K
YoY Change -100.0% 8261.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.642M 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -397.9K -133.0K -129.2K
Cash From Investing Activities -40.00K 0.000 179.8K
Cash From Financing Activities 9.642M 0.000 0.000
Net Change In Cash 9.204M -133.0K 50.55K
YoY Change -7411.12% -363.05% -217.89%
FREE CASH FLOW
Cash From Operating Activities -$397.9K -$133.0K -$129.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001605481
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 NGLD Obligation To Issue Shares
ObligationToIssueShares
usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2023Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
NGLD Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
NGLD Stockbased Compensation Issued To Consultants
StockbasedCompensationIssuedToConsultants
usd
NGLD Stockbased Compensation Issued To Officer
StockbasedCompensationIssuedToOfficer
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
NGLD Mineral Interests Acquired With Related Parties Payables Net
MineralInterestsAcquiredWithRelatedPartiesPayablesNet
usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55600
dei Entity Registrant Name
EntityRegistrantName
NEVADA CANYON GOLD CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5152859
dei Entity Address Address Line1
EntityAddressAddressLine1
5655 Riggins Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 15
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89502
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
909-5548
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
NGLD
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11632950 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
779198 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1007018 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9856 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4829 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
789054 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1011847 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
61843 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
156805 usd
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
760395 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
720395 usd
CY2023Q2 us-gaap Assets
Assets
1611292 usd
CY2022Q4 us-gaap Assets
Assets
1889047 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
809796 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
844963 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1309796 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1321994 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11077394 shares
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
377445 usd
us-gaap Operating Expenses
OperatingExpenses
1063474 usd
us-gaap Operating Expenses
OperatingExpenses
456790 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
174830 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
301392 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-6224 usd
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11077394 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11077394 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11077394 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1107 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1107 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11077394 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11077394 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11077394 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11077394 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1107 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1107 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3563620 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3073447 usd
CY2023Q2 NGLD Obligation To Issue Shares
ObligationToIssueShares
388889 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3652120 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2507501 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
301496 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
567053 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1611292 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1889047 usd
CY2023Q2 NGLD Consulting Fees
ConsultingFees
124167 usd
CY2022Q2 NGLD Consulting Fees
ConsultingFees
7597 usd
NGLD Consulting Fees
ConsultingFees
179493 usd
NGLD Consulting Fees
ConsultingFees
21726 usd
CY2023Q2 NGLD Director And Officer Compensation Expense
DirectorAndOfficerCompensationExpense
421440 usd
CY2022Q2 NGLD Director And Officer Compensation Expense
DirectorAndOfficerCompensationExpense
313417 usd
NGLD Director And Officer Compensation Expense
DirectorAndOfficerCompensationExpense
723506 usd
NGLD Director And Officer Compensation Expense
DirectorAndOfficerCompensationExpense
358191 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50851 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5876 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75565 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10741 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
70320 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
48010 usd
us-gaap Professional Fees
ProfessionalFees
76320 usd
us-gaap Professional Fees
ProfessionalFees
56332 usd
CY2023Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
3868 usd
CY2022Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
2545 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
8590 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
9800 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
670646 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-163284 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-94962 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
203850 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8211 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-967 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7321 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
827 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13813 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
888 usd
CY2022Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-56325 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
211530 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1101 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-401823 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81145 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113909 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-669545 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-779268 usd
us-gaap Net Income Loss
NetIncomeLoss
-1144619 usd
us-gaap Net Income Loss
NetIncomeLoss
-342881 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7074061 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2680093 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7074061 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2680093 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7074061 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2680093 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7074061 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2680093 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239944 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44774 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
436387 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
721105 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
313417 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-779268 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
255254 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
567053 usd
CY2023Q1 NGLD Stock Based Compensation Obligation To Issue Shares For Consultants
StockBasedCompensationObligationToIssueSharesForConsultants
38889 usd
CY2023Q1 NGLD Stock Based Compensation Obligation To Issue Shares For Officer
StockBasedCompensationObligationToIssueSharesForOfficer
58333 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243733 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-475074 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
432934 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
432934 usd
CY2023Q2 NGLD Stock Based Compensation Obligation To Issue Shares For Consultants
StockBasedCompensationObligationToIssueSharesForConsultants
116667 usd
CY2023Q2 NGLD Stock Based Compensation Obligation To Issue Shares For Officer
StockBasedCompensationObligationToIssueSharesForOfficer
175000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
246440 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-669545 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-669545 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
301496 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
301496 usd
us-gaap Net Income Loss
NetIncomeLoss
-1144619 usd
us-gaap Net Income Loss
NetIncomeLoss
-342881 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
301392 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-94962 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
203850 usd
NGLD Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
-967 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
211530 usd
NGLD Stockbased Compensation Directors And Ceo
StockbasedCompensationDirectorsAndCeo
490173 usd
NGLD Stockbased Compensation Directors And Ceo
StockbasedCompensationDirectorsAndCeo
358191 usd
NGLD Stockbased Compensation Issued To Consultants
StockbasedCompensationIssuedToConsultants
155556 usd
NGLD Stockbased Compensation Issued To Officer
StockbasedCompensationIssuedToOfficer
233333 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5027 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
21182 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15167 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12104 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-42905 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17031 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-27000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207820 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200902 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
614658 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
20000 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
410000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
204658 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
400 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-967 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227820 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3189 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1007018 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1420864 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
779198 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1424053 usd
us-gaap Share Based Compensation
ShareBasedCompensation
358191 usd
NGLD Mineral Interests Acquired With Related Parties Payables Net
MineralInterestsAcquiredWithRelatedPartiesPayablesNet
20000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_806_eus-gaap--NatureOfOperations_zyeP6j27b22e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_821_zAnLR6hJinBb">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada Canyon Gold Corp. (the “Company”) was incorporated under the laws of the state of <span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20230101__20230630_zgG0wu9uGphb" title="State of incorporation">Nevada</span> on <span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230630_zSKihrMJ7Jme" title="Date of incorporation">February 27, 2014</span>. On July 6, 2016, the Company changed its name from Tech Foundry Ventures, Inc. to Nevada Canyon Gold Corp. On December 15, 2021, the Company incorporated two subsidiaries, Nevada Canyon LLC and Canyon Carbon LLC. Both subsidiaries were incorporated under the laws of the state of Nevada. The Company is involved in acquiring and exploring mineral properties and royalty interests in Nevada and Idaho.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements are prepared using accounting principles generally accepted in the United States of America (“US GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company is in a business of acquiring and exploring mineral properties and royalty interests and has not generated or realized any revenues from these business operations. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to the amounts and classifications of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. Management intends to obtain additional funding by borrowing funds, and/or a private placement of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-02-27
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
421440 usd
CY2022Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
313417 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
723506 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
358191 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so, elect all of the directors of the Company.
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
538107 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
313417 usd
us-gaap Share Based Compensation
ShareBasedCompensation
879062 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
980000 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
15064 usd
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
20000 usd
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
174830 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
301392 usd

Files In Submission

Name View Source Status
0001493152-23-027763-index-headers.html Edgar Link pending
0001493152-23-027763-index.html Edgar Link pending
0001493152-23-027763.txt Edgar Link pending
0001493152-23-027763-xbrl.zip Edgar Link pending
ex10-20.htm Edgar Link pending
ex10-20_002.jpg Edgar Link pending
ex10-20_003.jpg Edgar Link pending
ex10-20_004.jpg Edgar Link pending
ex10-20_005.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
ngld-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ngld-20230630_lab.xml Edgar Link unprocessable
ngld-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ngld-20230630_def.xml Edgar Link unprocessable
ngld-20230630_cal.xml Edgar Link unprocessable